Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock
[PR Newswire] – BLUE BELL, Pa., Feb. 27, 2014 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) (Inovio or the Company), today announced the pricing of an underwritten public offering of 18,966,000 shares of common stock for a public offering more
View todays social media effects on INO
View the latest stocks trending across Twitter. Click to view dashboard